Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Gastroesophageal Reflux Disease (GERD)
Interventions
DRUG

AZD3355

Trial Locations (38)

Unknown

Research Site, Adelaide

Research Site, Brussels

Research Site, Eupen

Research Site, Wilrijk

Research Site, Alès

Research Site, Angers

Research Site, Bordeaux

Research Site, Lyon

Research Site, Nantes

Research Site, Cologne

Research Site, Koblenz

Research Site, Ludwigshafen

Research Site, München

Research Site, Oelde

Research Site, Potsdam

Research Site, Wangen

Research Site, Wiesbaden

Research Site, Budapest

Research Site, Győr

Research Site, Nagykanizsa

Research Site, Pécs

Research Site, Siófok

Research Site, Szeged

Research Site, Szombathely

Research Site, Vác

Research Site, Amsterdam

Research Site, Ålesund

Research Site, Bergen

Research Site, Levanger

Research Site, Oslo

Research Site, Rud

Research Site, Stavanger

Research Site, Tromsø

Research Site, Trondheim

Research Site, Brasov

Research Site, Bucharest

Research Site, Satu Mare

Research Site, Târgu Mureş

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY